Accepted for/Published in: JMIR Research Protocols
Date Submitted: Jun 6, 2023
Date Accepted: Sep 18, 2023
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Adaptive Intervention to Prevent Respiratory Illness in Cerebral Palsy: Protocol for a Feasibility Pilot Randomized Controlled Trial
ABSTRACT
Background:
This study will pilot test an innovative just-in-time adaptive intervention to reduce severe respiratory illness for children with severe cerebral palsy (CP). Our intervention program, RE-PACT (Respiratory Exacerbation – Plans for Action and Care Transitions), delivers timely, customized action planning and rapid clinical response when hospitalization risk is elevated.
Objective:
To establish RE-PACT’s feasibility, acceptability, and fidelity in up to 90 children with severe CP. An additional aim is to preliminarily estimate RE-PACT’s effect size.
Methods:
RE-PACT will be run through three successively larger 6-month trial waves, allowing ongoing protocol refinement according to pre-specified definitions of success for measures of feasibility, acceptability, and fidelity.
Results:
Feasibility measures include recruitment and intervention time. Acceptability measures include recruitment and completion rates as well as intervention satisfaction. Fidelity measures include observed versus expected rates of intervention and data collection activities. The primary clinical outcome is a severe respiratory illness, defined as a respiratory diagnosis requiring hospitalization. Secondary clinical outcomes include hospital days and emergency department visits, systemic steroid courses, systemic antibiotic courses, and death from severe respiratory illness.
Conclusions:
This pilot intervention, using adaptive just-in-time strategies, represents a novel approach to reducing the incidence of significant respiratory illness for children with severe cerebral palsy. This protocol may be helpful to other researchers and healthcare providers caring for patients at high risk for acute severe illness exacerbations. Clinical Trial: ClinicalTrials.gov NCT05292365
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.